PDE6B and retinitis pigmentosa: To further confirm whether PEVsMH42-siCul7 serve as a promising strategy for RD therapy, we used Pde6βrd1/rd1 mutant mice which is a genetic mouse RD model with the same mutation of Pde6β as retinitis pigmentosa patients 24.